Today, the Commonwealth Fund published a blog post on the Bipartisan Budget Act of 2018, which will have an impact on Medicaid drug prices.
The Trump administration laid out a package of proposals to lower drug costs in the president’s budget for fiscal year 2019.
The CREATES Act tackles one of the numerous problems driving high drug prices that Waxman Strategies described in their recent report.
Mighty Earth’s investigation finds that cocoa used in the chocolate produced by Mars, Nestle, Hershey’s and Godiva was grown illegally in protected areas.
Mighty Earth’s new investigation traces responsibility for a massive dead zone in the Gulf of Mexico to specific companies, notably Tyson Foods, America’s largest meat company.
The report identifies the problems and drivers of high prescription drug prices as well as the many actions that can be taken to address them.
Henry highlights how the Republican healthcare bill would dismantle more than just Obamacare but gut a guarantee of healthcare for the poor.
Waxman Strategies is pleased to announce two new additions to its growing public relations practice, Senior Vice President Kirsten Maynard and Senior Account Executive Kemba Neptune.
With the withdrawal of the U.S. from the Paris Climate Accord by Pres. Trump, Henry argues that the private sector provides the best opportunity for progress in reducing greenhouse gas emissions.
The current flexibility of Medicaid is a lifeline we can’t afford to compromise.